| |
|
|
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Caprinos e Ovinos. |
|
Data corrente: |
06/02/2017 |
|
Data da última atualização: |
06/09/2021 |
|
Tipo da produção científica: |
Resumo em Anais de Congresso |
|
Autoria: |
OLIVEIRA, C. T. de M.; TEIXEIRA, M. |
|
Afiliação: |
Clarissa Torres de Melo Oliveira; MARCEL TEIXEIRA, CNPC. |
|
Título: |
Monitoramento clínico e laboratorial de cabras vacinadas contra Haemonchus contortus. |
|
Ano de publicação: |
2016 |
|
Fonte/Imprenta: |
In: ENCONTRO DE INICIAÇÃO CIENTÍFICA DA EMBRAPA CAPRINOS E OVINOS, 5., 2016, Sobral. Anais... Sobral: Embrapa Caprinos e Ovinos, 2016. p. 34-35. |
|
Idioma: |
Português |
|
Conteúdo: |
No Brasil, dentre as espécies de parasitos do trato gastrointestinal, Haemonchus contortus é considerada a de maior importância na produção de pequenos ruminantes, oferecendo maior risco aos animais e implicando em prejuízos aos rebanhos nacionais. O seu controle é baseado principalmente no uso de anti-helmínticos, porém, falhas nesse tipo de controle contribuem para o aumento da resistência anti-helmíntica. Portanto, o uso de uma medida preventiva capaz de reduzir a contaminação ambiental e a carga parasitária dos animais acarretaria em grande benefício para a cadeia produtiva. O estudo com imunização e infecção experimental demonstra que há proteção substancial conferida contra H. contortus e evidencia a vacina como uma ferramenta para manter os baixos níveis de contaminação de pasto. |
|
Palavras-Chave: |
Monitoramento. |
|
Thesagro: |
Anti-helmíntico; Cabra leiteira; Caprino; Haemonchus contortus; Helminto gastrintestinal; Imunização; Vacina. |
|
Thesaurus Nal: |
Anthelmintics; Goats; Immunization; Vaccines. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
URL: |
https://ainfo.cnptia.embrapa.br/digital/bitstream/item/154780/1/cnpc-2016-Monitoramento.pdf
|
|
Marc: |
LEADER 01678nam a2200265 a 4500
001 2062794
005 2021-09-06
008 2016 bl uuuu u00u1 u #d
100 1 $aOLIVEIRA, C. T. de M.
245 $aMonitoramento clínico e laboratorial de cabras vacinadas contra Haemonchus contortus.$h[electronic resource]
260 $aIn: ENCONTRO DE INICIAÇÃO CIENTÍFICA DA EMBRAPA CAPRINOS E OVINOS, 5., 2016, Sobral. Anais... Sobral: Embrapa Caprinos e Ovinos, 2016. p. 34-35.$c2016
520 $aNo Brasil, dentre as espécies de parasitos do trato gastrointestinal, Haemonchus contortus é considerada a de maior importância na produção de pequenos ruminantes, oferecendo maior risco aos animais e implicando em prejuízos aos rebanhos nacionais. O seu controle é baseado principalmente no uso de anti-helmínticos, porém, falhas nesse tipo de controle contribuem para o aumento da resistência anti-helmíntica. Portanto, o uso de uma medida preventiva capaz de reduzir a contaminação ambiental e a carga parasitária dos animais acarretaria em grande benefício para a cadeia produtiva. O estudo com imunização e infecção experimental demonstra que há proteção substancial conferida contra H. contortus e evidencia a vacina como uma ferramenta para manter os baixos níveis de contaminação de pasto.
650 $aAnthelmintics
650 $aGoats
650 $aImmunization
650 $aVaccines
650 $aAnti-helmíntico
650 $aCabra leiteira
650 $aCaprino
650 $aHaemonchus contortus
650 $aHelminto gastrintestinal
650 $aImunização
650 $aVacina
653 $aMonitoramento
700 1 $aTEIXEIRA, M.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Caprinos e Ovinos (CNPC) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Gado de Leite. Para informações adicionais entre em contato com cnpgl.biblioteca@embrapa.br. |
Registro Completo
|
Biblioteca(s): |
Embrapa Gado de Leite. |
|
Data corrente: |
11/08/2021 |
|
Data da última atualização: |
11/08/2021 |
|
Tipo da produção científica: |
Nota Técnica/Nota Científica |
|
Autoria: |
FONSECA, M. D. M.; MAIA, J. M. S.; VARAGO, F. C.; GERN, J. C.; CARVALHO, W. A.; SILVA, S. R.; MOSQUEIRA, V. C. F.; BRANDAO, H. de M.; GUIMARÃES, A. S. |
|
Afiliação: |
Universidade Federal de Lavras; Universidade Federal de Lavras; JULIANA CARINE GERN, CNPGL; WANESSA ARAUJO CARVALHO, CNPGL; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; HUMBERTO DE MELLO BRANDAO, CNPGL; ALESSANDRO DE SA GUIMARAES, CNPGL. |
|
Título: |
Cloxacillin nanostructured formulation for the treatment of bovine keratoconjunctivitis. |
|
Ano de publicação: |
2020 |
|
Fonte/Imprenta: |
Veterinary and Animal Science, v. 9, 100089, 2020. |
|
DOI: |
https://doi.org/10.1016/j.vas.2020.100089 |
|
Idioma: |
Inglês |
|
Notas: |
Short communication. |
|
Conteúdo: |
Infectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoadhesive characteristics of the nanoparticle. The results indicate that the use of nanocoated cloxacillin is possible to control infectious bovine keratoconjunctivitis. MenosInfectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoad... Mostrar Tudo |
|
Palavras-Chave: |
Ceratoconjuntivite; Cloxacilina; Nanoestrutura; Nanopartícula mucoadesiva. |
|
Thesagro: |
Bovino; Doença Animal; Moraxella Bovis. |
|
Categoria do assunto: |
L Ciência Animal e Produtos de Origem Animal |
|
Marc: |
LEADER 02630naa a2200325 a 4500
001 2133453
005 2021-08-11
008 2020 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1016/j.vas.2020.100089$2DOI
100 1 $aFONSECA, M. D. M.
245 $aCloxacillin nanostructured formulation for the treatment of bovine keratoconjunctivitis.$h[electronic resource]
260 $c2020
500 $aShort communication.
520 $aInfectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoadhesive characteristics of the nanoparticle. The results indicate that the use of nanocoated cloxacillin is possible to control infectious bovine keratoconjunctivitis.
650 $aBovino
650 $aDoença Animal
650 $aMoraxella Bovis
653 $aCeratoconjuntivite
653 $aCloxacilina
653 $aNanoestrutura
653 $aNanopartícula mucoadesiva
700 1 $aMAIA, J. M. S.
700 1 $aVARAGO, F. C.
700 1 $aGERN, J. C.
700 1 $aCARVALHO, W. A.
700 1 $aSILVA, S. R.
700 1 $aMOSQUEIRA, V. C. F.
700 1 $aBRANDAO, H. de M.
700 1 $aGUIMARÃES, A. S.
773 $tVeterinary and Animal Science$gv. 9, 100089, 2020.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Gado de Leite (CNPGL) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Expressão de busca inválida. Verifique!!! |
|
|
